Bristol-Myers (BMY) August volatility at 28 after trial id did not meet its primary endpoint

August 5, 2016 12:59 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Bristol-Myers Squibb (NYSE: BMY) August weekly call option implied volatility is at 29, August is at 28; compared to its 52-week range of 20 to 43 after announcing that CheckMate -026, a trial investigating the use of Opdivo as monotherapy, did not meet its primary endpoint

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Options, mrk

Add Your Comment